文献速递小儿眼科与斜弱视

弱视的双目治疗:美国眼科学会报告

Binocular Treatment of Amblyopia: A Report by the American Academy of Ophthalmology.
PubMed 文献 · Ophthalmology · 2019-10-13

该报告由美国眼科学会基于PubMed和Cochrane图书馆数据库截至2019年4月的文献,评估双目治疗对比标准疗法治疗弱视的疗效。共纳入20项研究(6项I级、1项II级、13项III级)。结论认为尚无I级证据支持双目治疗替代现有弱视疗法(包括遮盖和光学治疗),两项大型随机对照试验显示其疗效劣于标准遮盖治疗,因此不能推荐双目治疗作为标准弱视治疗的替代方案,但需进一步研究其未来潜在获益。

要点

  • 2项I/II级研究(共147例)显示双目治疗组视力较标准遮盖治疗显著改善。
  • 5项未显示视力改善的研究规模更大、设计更严谨(共813例)。
  • I/II级研究未显示双目治疗在感觉状态(抑制深度和立体视)较基线显著改善。

核心结论

  • 无I级证据支持双目治疗作为当前弱视疗法(包括遮盖和光学治疗)的替代方案。
  • 两项大型随机对照试验显示双目治疗疗效劣于标准遮盖治疗。
  • 基于已发表文献综述,不能推荐双目治疗替代标准弱视治疗,但需进一步研究以确定未来拟议双目治疗的潜在获益。

研究设计与样本

  • 美国眼科学会报告,通过系统文献综述评估双目治疗对比标准治疗弱视的疗效。
  • 在PubMed和Cochrane图书馆数据库进行无日期限制、限英文的文献检索,2018年1月首次检索,2019年4月更新。
  • 检索获得286条引文,审阅50篇全文,20篇符合纳入标准并由方法学家进行证据等级评定。
  • 6项研究为I级,1项为II级,13项为III级(因对该技术发展和推广的影响)。

主要发现

  • 2项I/II级研究(共147例)描述双目治疗组视力较标准遮盖治疗显著改善。
  • 5项未能显示双目治疗较标准治疗视力改善的研究规模更大、设计更严谨(共813例)。
  • I/II级研究未能显示双目治疗者在感觉状态(包括抑制深度和立体视)较基线显著改善。
  • 13项较小III级病例系列(共163例)显示较I/II级研究中的双目治疗更有希望的结果,尤其使用更具吸引力且依从性更好的治疗时。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文指出需要更多研究来确定未来拟议双目治疗的潜在获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To review the published literature assessing the efficacy of binocular therapy for the treatment of amblyopia compared with standard treatments. METHODS: Literature searches with no date restrictions and limited to the English language were conducted in January 2018 and updated in April 2019 in the PubMed database and the Cochrane Library database with no restrictions. The search yielded 286 citations, and the full text of 50 articles was reviewed. Twenty articles met the inclusion criteria for this assessment and were assigned a level of evidence rating by the panel methodologist. Six studies were rated level I, 1 study was rated level II, and 13 studies were rated level III because of the impact on the development and popularization of this technology. RESULTS: Two of the level I and II studies reviewed described a significant improvement in visual acuity in the binocular group versus standard patching standard treatment (the total number of patients in these 2 studies was 147). However, the 5 studies that failed to show a visual improvement from binocular therapy compared with standard treatments were larger and more rigorously designed (the total number of patients in these 5 studies was 813). Level I and II studies also failed to show a significant improvement over baseline in sensory status, including depth of suppression and stereopsis of those treated with binocular therapy. Several smaller level III case series (total number of patients in these 13 studies was 163) revealed more promising results than the binocular treatments studied in the level I and II studies, especially using treatments that are more engaging and are associated with better compliance. CONCLUSIONS: There is no level I evidence to support the use of binocular treatment as a substitute for current therapies for amblyopia (including patching and optical treatment). Furthermore, 2 large randomized controlled trials showed inferior performance compared with standard patching treatment. On the basis of this review of the published literature, binocular therapy cannot be recommended as a replacement for standard amblyopia therapy. However, more research is needed to determine the potential benefits of proposed binocular treatments in the future.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Pineles SL, Aakalu VK, Hutchinson AK, et al. Binocular Treatment of Amblyopia: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019. PMID: 31619356. doi:10.1016/j.ophtha.2019.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。